Early mobilization after protamine reversal of heparin following implantation of phosphorylcholine- coated stents in totally occluded coronary arteries

American Journal of Cardiology

Volumn 85, Issue 6, 2000, Pages 698-702

  Kuiper, Karel K J ^a   Nordrehaug, Jan Erik ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; PHOSPHORYLCHOLINE; PROTAMINE SULFATE; TICLOPIDINE;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INJECTION; LUNG EDEMA; MALE; MOBILIZATION; OUTPATIENT; PRIORITY JOURNAL; THROMBOSIS;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EARLY AMBULATION; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; PROTAMINES; STENTS; TIME FACTORS;

EID: 0034653823     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00843-7     Document Type: Article

References (28)

1. Ferguson J.J., Dougherty K.G., Gaos C.M., Bush H.S., Marsh K.C., Leachman D.R. Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 23:1994;1061-1065.
2. Grayburn P.A., Willard J.E., Brickner M.E., Eichhorn E.J. In vivo thrombus formation on a guide wire during intravascular ultrasound imaging evidence for inadequate heparinization . Cathet Cardiovasc Diagn. 23:1991;141-143.
3. Ellis S.G., Roubin G.S., Wilentz J., Douglas J.S. Jr, King S.B. III. Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 117:1989;777-782.
4. Garachemani A.R., Kaufmann U., Fleisch M., Meier B. Prolonged heparin after uncomplicated coronary interventions a prospective, randomized trial . Am Heart J. 136:1998;352-356.
5. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 336:1997;1689-1696.
6. Koch K.T., Piek J.J., de winter R.J., David G.K., Mulder K., Tijssen J.G., Lie K.I. Safety of low dose heparin in elective coronary angioplasty. Heart. 77:1997;517-522.
7. Kereiakes D.J., Broderick T.M., Whang D.D., Anderson L., Fye D. Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention. Am J Cardiol. 80:1997;633-634.
8. Howlett J.G., Teskey R.J., O'Neill B.J. Spontaneous pericardial tamponade during PTCA. Can J Cardiol. 11:1995;927-930.
9. Kuiper K.K.J., Robinson K.A., Chronos N.A., Cui J., Palmer S.J., Nordrehaug J.E. Phosphorylcholine-coated metallic stents in rabbit iliac and porcine coronary arteries. Scand Cardiovasc J. 32:1998;261-268.
10. Chronos N.A.F., Robinson K.A., Kelly A.B., Taylor A., Yianni J., King S.B. III, Harker L.A., Hansen S.R. Thromboresistant phosphorylcholine coating for coronary stents. (abstr) Circulation. 92:(suppl I):1995;I490.
11. Cumberland D.C. Serruys P.W., Kutryk M.J.B. Handbook of Coronary Stenting. 1998;203-212 Martin Dunitz Ltd, London, UK.
12. Kutryk M.J.B. Kutryk M.J.B., Serruys P.W. Coronary Stenting Current Perspectives . 1999;33-34 Martin Dunitz Ltd, London, UK.
13. Kerensky R.A., Azar G.J. Jr, Bertolet B., Hill J.A., Kutcher M.A. Venous activated clotting time after intra-arterial heparin effect of site of administration and timing of sampling . Cathet Cardiovasc Diagn. 37:1996;151-153.
14. Nygard O., Nordrehaug J.E., Refsum H., Ueland P.M., Farstad M., Vollset S.E. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 337:1997;230-236.
15. Diver D.J., Bier J.D., Ferreira P.E., Sharaf B.L., McCabe C., Thompson B., Chaitman B., Williams D.O., Braunwald E. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial). Am J Cardiol. 74:1994;531-537.
16. Nordrehaug J.E., Chronos N.A.F., Priestley K.A., Buller N.P., Foran J., Wainwright R., Vollset S.E., Sigwart U. Randomized evaluation of an inflatable femoral artery compression device after cardiac catheterization. J Interven Cardiol. 9:1996;381-387.
17. Pan M., Suarez de Lezo J., Medina A., Romero M., Hernandez E., Segura J., Melian F., Wanguemert F., Landin M., Benitez F., Amat M., Velasco F., Torres A. In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation. Am J Cardiol. 80:1997;1336-1338.
18. Horiguchi T., Enzan K., Mitsuhata H., Murata M., Suzuki M. Heparin-protamine complexes cause pulmonary hypertension in goats. Anesthesiology. 83:1995;786-791.
19. Neidhart P.P., Meier B., Polla B.S., Schifferli J.A., Morel D.R. Fatal anaphylactoid response to protamine after percutaneous transluminal coronary angioplasty. Eur Heart J. 13:1992;856-858.
20. Mochizuki T., Olson P.J., Szlam F., Ramsay J.G., Levy J.H. Protamine reversal of heparin affects platelet aggregation and activated clotting time after cardiopulmonary bypass. Anesth Analg. 87:1998;781-785.
21. Stewart W.J., McSweeney S.M., Kellett M.A., Faxon D.P., Ryan T.J. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation. 70:1984;788-792.
22. Reed D.C., Gascho J.A. The safety of protamine sulfate in diabetics undergoing cardiac catheterization. Cathet Cardiovasc Diagn. 14:1988;19-23.
23. Koch K.T., Piek J.J., de Winter R.J., Mulder K., David G.K., Lie K.I. Early ambulation after coronary angioplasty and stenting with six French guiding catheters and low-dose heparin. Am J Cardiol. 80:1997;1084-1086.
24. Kiemeneij F., Laarman G.J., Slagboom T., van der Wieken R. Outpatient coronary stent implantation. J Am Coll Cardiol. 29:1997;323-327.
25. Kiemeneij F., Laarman G.J., Odekerken D., Slagboom T., van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches the access study . J Am Coll Cardiol. 29:1997;1269-1275.
26. Stella P.R., Kiemeneij F., Laarman G.J., Odekerken D., Slagboom T., van der Wieken R. Incidence and outcome of radial artery occlusion following transradial artery coronary angioplasty. Cathet Cardiovasc Diagn. 40:1997;156-158.
27. Brachmann J., Ansah M., Kosinski E.J., Schuler G.C. Improved clinical effectiveness with a collagen vascular hemostasis device for shortened immobilization time following diagnostic angiography and percutaneous transluminal coronary angioplasty. Am J Cardiol. 81:1998;1502-1505.
28. Carere R.G., Webb J.G., Miyagishima R., Djurdev O., Ahmed T., Dodek A. Groin complications associated with collagen plug closure of femoral arterial puncture sites in anticoagulated patients. Cathet Cardiovasc Diagn. 43:1998;124-129.